The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.70133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Jing Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical and Basic Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Genetic Therapy, Neuromuscular Diseases, RNA Splicing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 286 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Science and Technology Project of Hebei Education Department.
Abstract (Originalsprache)
Eukaryotic genes contain non‐coding segments known as introns, which interrupt coding sequences. Consequently, eukaryotic transcription produces precursor messenger RNA (pre‐mRNA) that relies on precise splicing to remove highly diverse introns from the genome and to generate the mature mRNA essential for maintaining normal cellular activities. The extensive heterogeneity of neurons necessitates complex splicing regulation, particularly alternative splicing, to ensure the accuracy of gene expression in neurogenesis, signal transduction, and synaptic function and to maintain stability and adaptability in the nervous system. With the improvement of genetic testing technology, aberrant splicing has been identified as a contributing factor to the pathogenesis of neuromuscular disorders (NMDs) such as spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), myotonic dystrophy (DM), Charcot–Marie–Tooth disease (CMT), myasthenia gravis (MG), and multiple sclerosis (MS). Studying the correlation between splicing defects and neuromuscular disorders is crucial for gaining a more comprehensive understanding of the pathogenesis of these diseases and for developing effective therapies. In this review, we introduce the intricate process and key factors of pre‐mRNA splicing, with a focus on aberrant splicing and pathogenesis in several major neuromuscular disorders, providing an overview of the latest therapeutic strategies. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical and Basic Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Institute of Medical Sciences, the Second Hospital of Shandong University, Jinan, Shandong, China.
ORCID-Profile: Lin Cheng
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Science and Technology Project of Hebei Education Department
Zitieren
APA
Wu, J., Yan, S., Bian, Y., Liu, R., Lyu, X., Zhang, Z., Huang, S., Chen, T., & Cheng, L. (2025). The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70133
Vancouver
Wu J, Yan S, Bian Y, Liu R, Lyu X, Zhang Z, et al. The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70133
BibTeX
@article{Wu2025,
author = {Wu, Jing and Yan, Shuxuan and Bian, Yuqin and Liu, Rui and Lyu, Xinxing and Zhang, Zhaoxiang and Huang, Shuhong and Chen, Tao and Cheng, Lin},
title = {The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.70133}
}
EUVIMED